Company Filing History:
Years Active: 2004-2014
Title: Innovations by Nancy H. Colburn
Introduction
Nancy H. Colburn is a notable inventor based in Middletown, MD (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compositions and methods for treating conditions associated with the NF-κB pathway and cancer.
Latest Patents
Nancy H. Colburn holds two patents that showcase her innovative work. The first patent is titled "Nuclear factor kappa B pathway inhibitor composition and use of same." This invention provides a pharmaceutical composition comprising a specific compound and outlines methods for treating or preventing conditions linked to increased expression and/or activity of the NF-κB pathway. Additionally, it includes a method for diagnosing such conditions in individuals. The second patent is titled "Dominant negative deletion mutants of C-jun and their use in the prevention and treatment of cancer." This patent discloses the inhibition of AP-1 activity by dominant negative deletion mutants of c-jun, which is associated with the prevention of tumor promoter-induced neoplastic transformation. This invention aims to utilize these mutants as therapeutic agents in cancer prevention and treatment.
Career Highlights
Nancy H. Colburn is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. Her work at this prestigious institution has allowed her to focus on groundbreaking research that has the potential to impact public health significantly.
Collaborations
Some of her notable coworkers include Curtis J. Henrich and Moon-II Kang. Their collaborative efforts contribute to the advancement of research in their respective fields.
Conclusion
Nancy H. Colburn's innovative patents and her work at the National Institutes of Health highlight her dedication to advancing medical science. Her contributions to the understanding and treatment of critical health conditions demonstrate the importance of innovation in the pharmaceutical industry.